Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.39.1.3 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.2 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
M.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.82 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.30NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.23.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.466.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CP.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.7.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DN.1.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XRNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.350.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.39.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.122NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.6 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.32NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EP.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used